$84.75
+0.87
(+1.04%)▲
1.75%
Downside
Day's Volatility :1.93%
Upside
0.19%
27.07%
Downside
52 Weeks Volatility :29.97%
Upside
3.98%
Period | Healthequity Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 6.12% | 4.8% | 0.0% |
6 Months | 3.17% | 8.3% | 0.0% |
1 Year | 12.74% | 17.0% | 0.0% |
3 Years | 29.93% | 20.8% | -20.8% |
Market Capitalization | 7.3B |
Book Value | $24.7 |
Earnings Per Share (EPS) | 1.2 |
PE Ratio | 69.9 |
PEG Ratio | 0.91 |
Wall Street Target Price | 103.92 |
Profit Margin | 9.61% |
Operating Margin TTM | 20.24% |
Return On Assets TTM | 3.4% |
Return On Equity TTM | 5.15% |
Revenue TTM | 1.1B |
Revenue Per Share TTM | 12.73 |
Quarterly Revenue Growth YOY | 23.1% |
Gross Profit TTM | 490.1M |
EBITDA | 337.4M |
Diluted Eps TTM | 1.2 |
Quarterly Earnings Growth YOY | 2.33 |
EPS Estimate Current Year | 2.19 |
EPS Estimate Next Year | 2.83 |
EPS Estimate Current Quarter | 0.7 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 22.62%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 287.2M | ↑ 25.15% |
Net Income | 73.9M | ↑ 56.03% |
Net Profit Margin | 25.73% | ↑ 5.1% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 532.0M | ↑ 85.21% |
Net Income | 39.7M | ↓ 46.33% |
Net Profit Margin | 7.46% | ↓ 18.27% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 733.6M | ↑ 37.89% |
Net Income | 8.8M | ↓ 77.73% |
Net Profit Margin | 1.2% | ↓ 6.26% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 756.6M | ↑ 3.13% |
Net Income | -44.3M | ↓ 601.35% |
Net Profit Margin | -5.85% | ↓ 7.05% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 861.7M | ↑ 13.9% |
Net Income | -26.1M | ↓ 40.97% |
Net Profit Margin | -3.03% | ↑ 2.82% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 999.6M | ↑ 16.0% |
Net Income | 55.7M | ↓ 313.1% |
Net Profit Margin | 5.57% | ↑ 8.6% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 244.4M | ↑ 4.53% |
Net Income | 4.1M | ↓ 2058.85% |
Net Profit Margin | 1.67% | ↑ 1.76% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 243.5M | ↓ 0.36% |
Net Income | 10.6M | ↑ 158.45% |
Net Profit Margin | 4.34% | ↑ 2.67% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 249.2M | ↑ 2.33% |
Net Income | 14.7M | ↑ 38.67% |
Net Profit Margin | 5.89% | ↑ 1.55% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 262.4M | ↑ 5.28% |
Net Income | 26.4M | ↑ 79.68% |
Net Profit Margin | 10.05% | ↑ 4.16% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 287.6M | ↑ 9.61% |
Net Income | 28.8M | ↑ 9.29% |
Net Profit Margin | 10.02% | ↓ 0.03% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 299.9M | ↑ 4.29% |
Net Income | 35.8M | ↑ 24.33% |
Net Profit Margin | 11.94% | ↑ 1.92% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 510.0M | ↑ 38.16% |
Total Liabilities | 32.9M | ↑ 43.92% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.6B | ↑ 402.96% |
Total Liabilities | 1.5B | ↑ 4560.07% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.7B | ↑ 5.65% |
Total Liabilities | 1.3B | ↓ 13.27% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 3.1B | ↑ 14.65% |
Total Liabilities | 1.3B | ↓ 5.77% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 3.1B | ↓ 0.59% |
Total Liabilities | 1.2B | ↓ 4.88% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 3.2B | ↑ 4.78% |
Total Liabilities | 1.2B | ↑ 0.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↓ 1.74% |
Total Liabilities | 1.1B | ↓ 6.44% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.1B | ↑ 1.04% |
Total Liabilities | 1.1B | ↑ 0.04% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.1B | ↑ 0.88% |
Total Liabilities | 1.1B | ↓ 1.01% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 3.2B | ↑ 4.62% |
Total Liabilities | 1.2B | ↑ 8.68% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 3.2B | ↑ 0.31% |
Total Liabilities | 1.1B | ↓ 4.39% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 3.5B | ↑ 8.25% |
Total Liabilities | 1.4B | ↑ 18.17% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 113.4M | ↑ 38.82% |
Investing Cash Flow | 25.7M | ↓ 169.81% |
Financing Cash Flow | 22.9M | ↑ 57.44% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 105.9M | ↓ 6.67% |
Investing Cash Flow | -1.7B | ↓ 6885.02% |
Financing Cash Flow | 1.5B | ↑ 6301.23% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 181.6M | ↑ 71.57% |
Investing Cash Flow | -97.0M | ↓ 94.43% |
Financing Cash Flow | 52.4M | ↓ 96.43% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 141.0M | ↓ 22.37% |
Investing Cash Flow | -639.2M | ↑ 559.26% |
Financing Cash Flow | 394.9M | ↑ 653.24% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 150.7M | ↑ 6.85% |
Investing Cash Flow | -119.1M | ↓ 81.36% |
Financing Cash Flow | -2.7M | ↓ 100.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 31.5M | ↓ 43.17% |
Investing Cash Flow | -9.1M | ↓ 11.1% |
Financing Cash Flow | -51.0M | ↑ 4352.62% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 77.1M | ↑ 144.49% |
Investing Cash Flow | -10.2M | ↑ 12.19% |
Financing Cash Flow | -2.2M | ↓ 95.78% |
Sell
Neutral
Buy
Healthequity Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Healthequity Inc | 12.3% | 3.17% | 12.74% | 29.93% | 61.34% |
Solventum Corp | 1.21% | 8.28% | 0.12% | 0.12% | 0.12% |
Doximity, Inc. | 20.42% | 70.21% | 96.34% | -37.48% | -16.98% |
Veeva Systems Inc. | -6.78% | -1.93% | -3.29% | -27.22% | 37.63% |
Ge Healthcare Technologies Inc. | 6.1% | 6.3% | 33.11% | 50.06% | 50.06% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Healthequity Inc | 69.9 | 69.9 | 0.91 | 2.19 | 0.05 | 0.03 | NA | 24.7 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Doximity, Inc. | 55.0 | 55.0 | 2.42 | 0.9 | 0.17 | 0.11 | NA | 4.92 |
Veeva Systems Inc. | 55.3 | 55.3 | 1.17 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 26.21 | 26.21 | 2.38 | 4.25 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Healthequity Inc | Buy | $7.3B | 61.34% | 69.9 | 9.61% |
Solventum Corp | Hold | $10.8B | 0.12% | NA | 15.73% |
Doximity, Inc. | Hold | $8.2B | -16.98% | 55.0 | 32.53% |
Veeva Systems Inc. | Buy | $33.5B | 37.63% | 55.3 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $41.4B | 50.06% | 26.21 | 8.1% |
Insights on Healthequity Inc
Revenue is up for the last 5 quarters, 243.54M → 299.92M (in $), with an average increase of 5.0% per quarter
Netprofit is up for the last 11 quarters, -32.81M → 35.82M (in $), with an average increase of 167.0% per quarter
In the last 1 year, Doximity, Inc. has given 96.3% return, outperforming this stock by 83.6%
BlackRock Inc
Vanguard Group Inc
Wasatch Advisors LP
FMR Inc
State Street Corp
ClearBridge Advisors, LLC
healthequity is the nation’s oldest and largest dedicated health savings trustee. we help individuals and families build health savings, while empowering employers to spend less on benefits through innovative, integrated health care account administration and investment platforms, all backed by 24/7/365 service, personalized savings strategies and consumer education. healthequity partners–more than 14,000 employers and 60 national health plans–spend less on benefits and get more by leveraging healthequity’s acclaimed service and education. healthequity is an irs-approved nonbank hsa trustee. as of september 30, 2010, healthequity manages more than $640 million in health savings assets. and all healthequity-managed cash deposits are fdic-insured to the greatest extent allowed by law. founded by dr. stephen neeleman, a practicing trauma surgeon and author of the complete hsa guidebook, healthequity is based in salt lake city and has members and sales representatives nationwide. v
Organization | Healthequity Inc |
Employees | 3126 |
CEO | Mr. Jon Kessler |
Industry | Finance |
Spdr Bloomberg Barclays Intermediate Term Corp Bond Etf
$84.75
+1.04%
Spdr S&p 400 Mid Cap Value E
$84.75
+1.04%
Quidelortho Corp
$84.75
+1.04%
Artisan Partners Asset Management Inc.
$84.75
+1.04%
Acadia Pharmaceuticals Inc.
$84.75
+1.04%
Cg Oncology Inc.
$84.75
+1.04%
Evolent Health, Inc. - Class A Shares
$84.75
+1.04%
Hilltop Holdings Inc
$84.75
+1.04%
The St. Joe Co
$84.75
+1.04%